Year |
Citation |
Score |
2017 |
Wong KK, Liu Y, Li Y, Wang X, Liu F, Gao P, Quinn MM, Li F, Merlino AA, Benes CH, Liu Q, Gray NS. Gemcitabine and Chk1 inhibitor AZD7762 synergistically suppress the growth of Lkb1-deficient lung adenocarcinoma. Cancer Research. PMID 28754670 DOI: 10.1158/0008-5472.Can-17-0567 |
0.323 |
|
2017 |
Adeegbe D, Liu Y, Lizotte PH, Kamihara Y, Aref AR, Almonte C, Dries R, Li Y, Liu S, Wang X, Warner-Hatten T, Castrillon J, Yuan GC, Poudel-Neupane N, Zhang H, et al. Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-small Cell Lung Cancer. Cancer Discovery. PMID 28408401 DOI: 10.1158/2159-8290.Cd-16-1020 |
0.324 |
|
2016 |
Zhang H, Qi J, Reyes JM, Li L, Rao PK, Li F, Lin CY, Perry JA, Lawlor MA, Federation A, De Raedt T, Li YY, Liu Y, Duarte MA, Zhang Y, et al. Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer. Cancer Discovery. PMID 27312177 DOI: 10.1158/2159-8290.Cd-16-0164 |
0.306 |
|
2015 |
Mohammad HP, Smitheman KN, Kamat CD, Soong D, Federowicz KE, Van Aller GS, Schneck JL, Carson JD, Liu Y, Butticello M, Bonnette WG, Gorman SA, Degenhardt Y, Bai Y, McCabe MT, et al. A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. Cancer Cell. 28: 57-69. PMID 26175415 DOI: 10.1016/J.Ccell.2015.06.002 |
0.31 |
|
2015 |
Smitheman K, Cusan M, Liu Y, Butticello M, Pappalardi M, Foley J, Federowicz K, Aller GV, Kasparec J, Tian X, Suarez D, Schneck J, Carson J, McDevitt P, Ho T, et al. Abstract 3513: Inhibition of LSD1 for the treatment of cancer Cancer Research. 75: 3513-3513. DOI: 10.1158/1538-7445.Am2015-3513 |
0.352 |
|
2014 |
Christensen CL, Kwiatkowski N, Abraham BJ, Carretero J, Al-Shahrour F, Zhang T, Chipumuro E, Herter-Sprie GS, Akbay EA, Altabef A, Zhang J, Shimamura T, Capelletti M, Reibel JB, Cavanaugh JD, ... Liu Y, et al. Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell. 26: 909-22. PMID 25490451 DOI: 10.1016/J.Ccell.2014.10.019 |
0.308 |
|
2013 |
Liu Y, Marks K, Cowley GS, Carretero J, Liu Q, Nieland TJ, Xu C, Cohoon TJ, Gao P, Zhang Y, Chen Z, Altabef AB, Tchaicha JH, Wang X, Choe S, et al. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discovery. 3: 870-9. PMID 23715154 DOI: 10.1158/2159-8290.Cd-13-0015 |
0.309 |
|
2013 |
Kruger RG, Mohammad H, Smitheman K, Cusan M, Liu Y, Pappalardi M, Federowicz K, Van Aller G, Kasparec J, Tian X, Suarez D, Rouse M, Schneck J, Carson J, McDevitt P, et al. Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid Leukemia Blood. 122: 3964-3964. DOI: 10.1182/Blood.V122.21.3964.3964 |
0.339 |
|
2012 |
Chen Z, Cheng K, Walton Z, Wang Y, Ebi H, Shimamura T, Liu Y, Tupper T, Ouyang J, Li J, Gao P, Woo MS, Xu C, Yanagita M, Altabef A, et al. A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature. 483: 613-7. PMID 22425996 DOI: 10.1038/Nature10937 |
0.312 |
|
2012 |
Liu Y, Cowley GS, Cohoon TJ, Root DE, Kwok-kin W. Abstract LB-260: Identification of DTYMK and CHEK1 as therapeutic targets in LKB1 mutant non-small cell lung cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-260 |
0.324 |
|
2011 |
Asai T, Liu Y, Bae N, Nimer SD. The p53 tumor suppressor protein regulates hematopoietic stem cell fate. Journal of Cellular Physiology. 226: 2215-21. PMID 21660944 DOI: 10.1002/Jcp.22561 |
0.317 |
|
2009 |
Liu Y, Elf SE, Asai T, Miyata Y, Liu Y, Sashida G, Huang G, Di Giandomenico S, Koff A, Nimer SD. The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior. Cell Cycle (Georgetown, Tex.). 8: 3120-4. PMID 19755852 DOI: 10.4161/Cc.8.19.9627 |
0.318 |
|
2009 |
Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, Di Giandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J, Reva B, Koff A, Nimer SD. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell. 4: 37-48. PMID 19128791 DOI: 10.1016/J.Stem.2008.11.006 |
0.319 |
|
2009 |
Asai T, Liu Y, Giandomenico SD, Deblasio A, Menendez S, Antipin J, Reva B, Wevrick R, Nimer SD. Necdin Regulates Hematopoietic Stem Cell Quiescence and Sensitivity to Genotoxic Stress. Blood. 114: 379-379. DOI: 10.1182/Blood.V114.22.379.379 |
0.304 |
|
2007 |
Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV. Tumor promoting properties of the ETS protein MEF in ovarian cancer. Oncogene. 26: 4032-7. PMID 17213815 DOI: 10.1038/Sj.Onc.1210170 |
0.333 |
|
2006 |
Liu Y, Hedvat CV, Mao S, Zhu XH, Yao J, Nguyen H, Koff A, Nimer SD. The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Molecular and Cellular Biology. 26: 3114-23. PMID 16581786 DOI: 10.1128/Mcb.26.8.3114-3123.2006 |
0.306 |
|
2006 |
Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, Nimer SD. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell. 9: 175-87. PMID 16530702 DOI: 10.1016/J.Ccr.2006.02.017 |
0.301 |
|
Show low-probability matches. |